Full-Time

Clinical Trial Manager

Posted on 1/30/2025

HeartFlow

HeartFlow

501-1,000 employees

Non-invasive cardiac testing for heart disease

Compensation Overview

$85k - $140kAnnually

+ Cash Bonus + Stock Options

Senior

Remote in USA

Remote work is allowed, but candidates in Mountain View, California may be preferred.

Category
Healthcare Administration & Support
Medical, Clinical & Veterinary
Required Skills
Word/Pages/Docs
Google Cloud Platform
Excel/Numbers/Sheets
PowerPoint/Keynote/Slides
Requirements
  • Ability to work in a smaller team environment with a willing, all hands on deck attitude
  • Ability to manage multiple tasks and be comfortable working in an environment with shifting priorities
  • High attention to detail, accuracy, and quality and able to effectively prioritize multiple projects
  • Knowledge of ICH Guidelines, US FDA, and European clinical trial requirements and regulations
  • Excellent written and oral English communication skills required
  • Proficiency in computer programs and specifically in Microsoft office tools including Word, Excel and PowerPoint
  • Bachelor’s degree in science or health related field
  • Demonstrated 5 years minimum relevant experience required
Responsibilities
  • Participates in clinical research activities including management of clinical study sites, management of study documentation, vendor management, and completion of project management tasks
  • Develops clinical trial timelines, enrollment projections, and instructional materials in support of trial execution, including project, communication, monitoring, recruitment, risk mitigation, and contingency plans
  • Participates in and leads process improvement activities within the department and cross functionally, including SOP development
  • Conducts study start-up activities including the development of protocols, informed consent forms, source document worksheets, training presentations, etc.
  • Reviews site regulatory documents (informed consents, IRB approvals, research agreements) to ensure compliance with study requirements and GCPs
  • Maintains effective working relationships with investigators/investigational site research coordinators, and vendors including core labs and data management
  • Perform other duties as required for successfully completing studies, as necessary
Desired Qualifications
  • Experience in cardiovascular medical device clinical research a plus

HeartFlow provides a non-invasive cardiac test that helps visualize a patient's coronary arteries in detail. This technology allows physicians to diagnose and treat heart disease more effectively without the need for invasive procedures, which reduces risks for patients and costs for healthcare providers. HeartFlow's main clients are healthcare professionals seeking safer diagnostic methods. The company offers several analyses, including FFRCT Analysis and Plaque Analysis, all of which have received FDA clearance and are available in the U.S., U.K., Japan, and Canada. Unlike competitors, HeartFlow focuses on non-invasive solutions that enhance treatment planning. The goal is to improve cardiovascular care by making it safer and more efficient.

Company Size

501-1,000

Company Stage

Series F

Total Funding

$858.5M

Headquarters

Redwood City, California

Founded

2010

Simplify Jobs

Simplify's Take

What believers are saying

  • HeartFlow secured $215 million in Series F funding to scale operations and enhance products.
  • The GAMEFILM Registry collaboration expands HeartFlow's market by addressing unique cardiovascular risks.
  • HeartFlow's RoadMap Analysis increases adoption potential in clinical settings.

What critics are saying

  • Emerging AI-driven competitors could threaten HeartFlow's market share with similar technologies.
  • Algorithmic bias in AI models may lead to inaccurate diagnoses and legal liabilities.
  • Regulatory hurdles in international markets could delay HeartFlow's product adoption.

What makes HeartFlow unique

  • HeartFlow combines anatomy, physiology, and plaque analysis for comprehensive heart disease diagnostics.
  • HeartFlow's non-invasive FFRCT Analysis offers personalized 3D heart models for precise treatment.
  • HeartFlow's AI-driven technology aligns with updated AHA/ACC chest pain guidelines.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Remote Work Options

Stock Options

401(k) Company Match

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

0%

2 year growth

-2%
Hit Consultant
Jan 22nd, 2025
Heartflow And Boone Heart Institute Launch Gamefilm Registry To Study Heart Health In Retired Nfl Players

HeartFlow and Boone Heart Institute Launch GAMEFILM Registry to Study Heart Health in Retired NFL Players. by Fred Pennic 01/22/2025 Leave a Comment. What You Should Know: – HeartFlow, a global leader in AI-driven heart care solutions, and Boone Heart Institute, a renowned cardiovascular care provider in Denver, today announced the launch of the GAMEFILM Registry. – GAMEFILM Registry will utilize advanced imaging and AI technology to assess and better understand coronary artery disease (CAD) risk in retired National Football League (NFL) players.Understanding the Unique Cardiovascular Risks of Retired NFL PlayersCardiovascular disease remains the leading cause of death globally. Despite advancements in diagnostics, many heart attacks and strokes occur in individuals without prior symptoms. Early identification of high-risk individuals is critical for effective prevention and treatment. Retired NFL players often face unique cardiovascular health challenges due to the intense physical demands of their careers

GlobeNewswire
Oct 18th, 2024
HeartFlow Announces New Category I CPT Code from the American Medical Association for AI-Enabled Plaque Analysis to Assess Risk for Coronary Artery Disease

HeartFlow announces new Category I CPT code from the American Medical Association for ai-enabled Plaque Analysis to assess risk for coronary artery disease.

Medical Device Network
Jul 19th, 2024
HeartFlow launches plaque analysis platform for coronary artery disease

HeartFlow launches plaque analysis platform for coronary artery disease.

Stockhouse
Nov 1st, 2023
Corcept Appoints Monica Tellado as President, Emerging Markets

Corcept appoints Monica Tellado as President, Emerging Markets.

Aunt Minnie
Apr 19th, 2023
HeartFlow launches RoadMap Analysis software

Cardiovascular artificial intelligence (AI) software developer HeartFlow has released its RoadMap software for identifying stenoses in the coronary arteries on CT exams.

INACTIVE